Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 407
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00824993 | Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients | ||
| NCT00562770 | Oral Valganciclovir Versus Valacyclovir | ||
| NCT01101295 | The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. | ||
| NCT01417494 | 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer | ||
| NCT04363853 | Tocilizumab Treatment in Patients With COVID-19 | ||
| NCT03848052 | Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC) | ||
| NCT00226798 | Immunochemotherapy for Metastatic Renal Cell Carcinoma | ||
| NCT00495547 | SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome | ||
| NCT01790633 | Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests | ||
| NCT06068985 | Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade | ||
| NCT01953458 | Therapeutic Option for Hepatitis B and C: a French Cohort | ||
| NCT04759248 | Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer | ||
| NCT03697850 | Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy | ||
| NCT00875979 | A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab | ||
| NCT02914470 | Carboplatin-cyclophosphamide Combined With Atezolizumab | ||
| NCT05118724 | Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin | ||
| NCT03691077 | Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714 | ||
| NCT00769522 | FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia | ||
| NCT01944943 | Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia | ||
| NCT05525858 | KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II | ||
| NCT00938444 | Evaluation of the BRADA and ABILHAND Questionnaires | ||
| NCT06068998 | Molecular Characterization of Penile Cancers in Developing Countries | ||
| NCT02666898 | Phase II Trial GA101 Inbrutinib B CLL | ||
| NCT01226771 | Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 | ||
| NCT01593332 | Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis | ||
| NCT07365930 | NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy | ||
| NCT00407732 | Overcoming Psychiatric Barriers to the Treatment of Hepatitis C | ||
| NCT00201734 | Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary | ||
| NCT07336134 | PopSci CHW4CervixHealth | ||
| NCT01523340 | A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response | ||
| NCT01188707 | A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer | ||
| NCT04341181 | ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling | ||
| NCT03192215 | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke | ||
| NCT00264290 | Valganciclovir to Reduce T Cell Activation in HIV Infection | ||
| NCT00170170 | Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation | ||
| NCT00353457 | Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma | ||
| NCT00738829 | Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL | ||
| NCT00539838 | A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN) | ||
| NCT00363116 | A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients | ||
| NCT00262717 | Can Resistance Enhance Selection of Treatment? (CREST) | ||
| NCT05966233 | R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma | ||
| NCT01185223 | Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation | ||
| NCT02383290 | The Implementation of Pharmacogenomics Into Primary Care in British Columbia | ||
| NCT04578106 | Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy | ||
| NCT00050167 | Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | ||
| NCT01303887 | A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients | ||
| NCT05057234 | PRecision Oncology Evidence Development in Cancer Treatment - Liquid | ||
| NCT01423695 | Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer | ||
| NCT02099292 | Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma | ||
| NCT01633346 | Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients |
